Ecolab Inc.
ECL - NYSE - $257.73 ▲ +%0.84
-
Earnings Tue 4 Aug

Ecolab opens the
books on Tuesday evening.

10 analysts' median target is $330[FMP target], stock is $258, +28.0% upside potential. After Q1 +0.0% EPS beat[FMP earnings], the stock moved -3.9%.

summary below
Quick Take - in 40 seconds
B
BUY Council 4/6 - Moonshot 44

B = MoonshotScore 44[9-pillar formula] + Council 4/6[6-lens rule]. Form 4: 0 transactions[FMP Form 4].

Q1 consensus: revenue $4.4B[FMP est], EPS $2.11[FMP est]. 0 consecutive quarters of beat[FMP earnings].

$2.11 EPS Estimate Last year $1.70 - +12% YoY YoY
0 Beat Streak Expectations beaten consecutively for the last 0 quarters

Q1 EPS +0.0% beat[FMP] but the stock -3.9% D+1[FMP D+1]. Scott Kirkland promised $332.1M CapEx + a sequential decline in Q1 during the Q1 earnings call[Scott Kirkland capex transcript].

Watchlist

6 metrics stand out this quarter.

70 Risk Indicator

Oi Margin Expansion

oi_margin_expansion

Ecolab expanded organic operating income margin by 70 basis points to 16.8%, driven by strong value pricing and improved SG&A productivity, and expects OI margin expansion to improve in the second half of the year.

"As a result, organic operating income margin expanded by 70 basis points to 16.8%. We expect OI margin expansion to improve in the second half of the year as pricing accelerates, and we remain very confident in delivering on our 20% OI margin target by '27."

- Christophe Beck - Q1 FY26 Earnings Call - April 28, 2026
11% Investor Focus

Life Sciences Growth

life_sciences_growth

Ecolab's Life Sciences division grew 11%, led by bioprocessing where sales more than doubled, and expects operating income margins to expand toward its 30% target over the next few years.

"Life Sciences accelerated to 11% growth, led by bioprocessing where sales more than doubled. We expect Life Sciences growth to continue its double-digit momentum and operating income margins to expand toward our 30% target over the next few years."

- Christophe Beck - Q1 FY26 Earnings Call - April 28, 2026
7% Investor Focus

Pest Elimination Growth

pest_elimination_growth

Ecolab's Pest Elimination delivered a strong quarter with 7% growth, reflecting strong share gains from our One Ecolab growth initiative and our new Pest Intelligence offering.

"Pest Elimination delivered a strong quarter with 7% growth, reflecting strong share gains from our One Ecolab growth initiative and naturally, our new Pest Intelligence offering."

- Christophe Beck - Q1 FY26 Earnings Call - April 28, 2026
20% Investor Focus

High Tech Growth

high_tech_growth

Ecolab's Global High-Tech and digital segments grew more than 20%, driven by strong demand tied to digital adoption and the ongoing AI build-out.

"Global High-Tech and digital both grew more than 20%, driven by strong demand tied to digital adoption and the ongoing AI build-out."

- Christophe Beck - Q1 FY26 Earnings Call - April 28, 2026
12% Investor Focus

Coolit Acquisition Impact

coolit_acquisition_impact

The acquisition of CoolIT is expected to accelerate Ecolab's earnings per share (EPS) growth back into the 12% to 15% range, after short-term impacts, as amortization from the Nalco acquisition rolls off.

"Beyond the short-term impact this year, we expect EPS growth, including CoolIT to accelerate back into the 12% to 15% range as contributions from this high-growth, high-margin acquisition accelerate and amortization from the Nalco acquisition rolls up."

- Christophe Beck - Q1 FY26 Earnings Call - April 28, 2026
April 1 Investor Focus

Commodity Cost Impact

commodity_cost_impact

Ecolab is implementing an energy surcharge to offset rising commodity costs, aiming to fully offset the impact on second-quarter EPS growth.

"However, the magnitude of energy cost increases requires additional action to ensure reliable supply, which is why we quickly implemented an energy surcharge. This is an approach we've used successfully before, focused on delivering incremental total value for customers that exceeds the total price increase."

- Christophe Beck - Q1 FY26 Earnings Call - April 28, 2026

Stock Expert AI - Methodology

Do our 9 pillars, 7 perspectives, and Munger lens point in the same direction?

Council Score 4 / 6 Bullish

6 investor frameworks. 4 bullish (Ray Dalio, Klarman, Buffett, Munger), 1 bearish (Ken Griffin), 1 neutral (Jim Simons).

How is it calculated? ->
Ray Dalio macro - target upside +28.0%
Ken Griffin flow - 50d MA below
Jim Simons quant - RSI 39
Klarman value - target upside +28.0%
Buffett quality - ROE score 5/5
Munger valuation - target upside +28.0%
Munger's Mindset character & balance sheet lens
Undervalued

Quality business, discounted price.

How is it calculated? ->
Financial HealthModerate
Margin of SafetyStrong
Interest CoverageAdequate
ROIC vs WACCHealthy
Technical Levels - Pre-earnings positioning

What levels is the stock being tested at?

RSI(14)
38.9 RSI 38.9 weak momentum, 50d below
MACD
-5.80 price below 50d - resistance dominant
50d MA
$274 stock 5.8% below - short-term resistance
200d MA
$273 stock 5.5% below - long-term pressure
Volume (10d)
-88% decrease - low participation
Resistance
$330
Analyst median target - upgrade trigger if broken
Current
$258
Pre-earnings position
Support
$232
Invalidation - close below this is a technical breakdown
Pattern
Range
$232-$330 band - earnings breakout/breakdown trigger

Past Performance

Ecolab's last 8 quarters: 0 consecutive beats.

MISS
Q2 FY25
$1.89 vs $1.90 est - +1.4%
MISS
Q3 FY25
$2.07 vs $2.07 est - -4.0%
BEAT
Q4 FY25
$2.08 vs $2.07 est - +1.3%
MISS
Q1 FY26
$1.70 vs $1.70 est - -3.9%

Q1 (April 28, 2026): EPS $1.70 vs $1.70 est[FMP], +0.0% beat. D+1 movement: -3.9%[FMP D+1]. Decline despite beat - market reacted to guidance, not numbers.

Three scenarios: what could happen?

EPS < $2.05 (no guidance)

Q1: EPS $1.70 vs $1.70 beat[FMP], stock -3.9% D+1[FMP].

Backlog concentration

No RPO/backlog concentration disclosed in Q1 earnings call.

CapEx shock

Q1 CapEx $332.1M[FMP cashflow]. Q1 op margin 15.3%[FMP op margin] - this level in Q1 is sensitive to CapEx revision risk.

Framework - Position discipline

After the data arrives: 3 scenarios, 3 windows

Not advice - a structural framework for earnings night. Decision discipline is yours.

Scenario A - Beat
Q1 EPS > $2.11 + CapEx discipline
Threshold: EPS > $2.11[FMP est].
Target: Break above median target $330[FMP target]; high target $345[FMP] upper bound.
Scenario B - In-Line
EPS approx $2.11 + CapEx < $332.1M
Threshold: EPS approx $2.11[FMP est], Q1 CapEx < $332.1M[FMP].
Target: Consolidation in the band between current $258[FMP] and median $330[FMP].
Scenario C - Miss
EPS < $2.05 or CapEx >= $332.1M
Threshold: EPS < $2.05[FMP estx0.97].
Target: Current $258 below SMA200 $273[FMP], if rejection continues, $232[derived] support activates.
Sizing
Earnings volatility -> max portfolio 1-2%. Waiting for earnings is not a gamble, it's a position entrustment.
Timing
IV crush within 24 hours post-earnings. Waiting for premium decay makes options preferable to spot.
Staging
Don't go all-in at once, divide into 3: initial reaction, 24 hours later, after Friday's close.

Market Outlook

What do 10 analysts say?

Wall Street Consensus
$330
12-month median target price (+28.0% upside potential)
19
BUY
8
HOLD
0
SELL
Risk Management
$232
Invalidation level - critical support threshold
$274 - 50-day MA (below, -5.8%)
$273 - 200-day MA (below, -5.5%)
IV Crush risk (sudden drop in inflated option premiums before earnings): Option premiums are inflated before earnings.
Verdict - ECL Q1 FY27
B

You read it in 5 minutes. When the numbers come out on Tuesday evening - you know what you're looking at.

Data arrives at night. The framework is ready now.

Data arrives on Tuesday evening. The framework is ready on this page: Q1 EPS threshold $2.11[FMP], CapEx threshold "below $332.1M"[Scott Kirkland]. Two anchors, three scenarios.

Comparison Stock Expert AI Pro $24/month ($240/year), 77% cheaper than the total of three earnings-tracking tools ($1,059/year -> $240/year).

3 subscriptions. 1 platform.

Seeking Alpha $299/yr - analyst opinions + earnings coverage TipRanks $360/yr - Smart Score (1-10) + analyst consensus + insider trades Trendspider $400/yr - AI pattern detection + automated TA + multi-timeframe alerts

Prices as of April 2026. Sources: seekingalpha.com/subscriptions - tipranks.com/pricing - trendspider.com/pricing

Stock Expert AI Pro: $24/month ($240/year). Council 7-lens analysis + MoonshotScore 9-pillar + Insider tracker + Technical levels - all in one platform, for every stock.

Educational tool, not investment advice. Past performance does not guarantee future results.

Calendar

Catalyst Calendar - 90-day forward look

Aug 4, 2026EARNINGSQ1 FY27 results (after market close) + earnings call
Aug 5, 2026PRICEFirst trading day after earnings - 200dMA test + IV crush
Sep 18, 2026FILING10-Q deadline - segment breakdown + RPO detail (SEC rule: quarter-end + 45 days)
~Nov 4, 2026EARNINGSQ2 FY27 (next quarter, date not yet scheduled in FMP)

DATA GAP: Events not in the FMP /stable/calendar feed - Investor day, analyst day, product launches, regulatory dates. These require company IR page scraping or manual calendar entry.

Frequently Asked Questions

What does the ECL earnings preview cover?

This ECL (ECL) earnings preview covers the analyst consensus, key catalysts, and what to watch on the earnings call.

What should investors watch for in ECL earnings?

Consensus EPS, revenue guidance, segment growth rates, and the tone of management commentary — the full breakdown with sources is on this page.